Vivek Ramaswamy
Founder chez Strive Asset Management LLC
Fortune : 563 M $ au 31/03/2024
Profil
Vivek Ramaswamy est un entrepreneur et un homme d'affaires qui a fondé Roivant Sciences GmbH, Roivant Sciences, Inc., Campus Venture Network, Inc. et Roivant Sciences Ltd. et qui a été à la tête de 10 entreprises différentes. Actuellement, M. Ramaswamy est président exécutif de Roivant Sciences Ltd, président exécutif de Roivant Sciences GmbH et président exécutif de Roivant Sciences, Inc. (les deux sont des filiales de Roivant Sciences Ltd.) et président de Montes Archimedes Acquisition Corp. M. Ramaswamy est également membre du conseil d'administration de Sumitovant Biopharma, Inc. Au cours de sa carrière, M. Ramaswamy a été président d'Arbutus Biopharma Corp. et président d'Arbutus Biopharma, Inc. (une filiale d'Arbutus Biopharma Corp.), directeur chez Sio Gene Therapies, Inc. et directeur général chez Axovant Sciences, Inc. (une filiale de Sio Gene Therapies, Inc.), président de Campus Venture Network, Inc. et analyste des investissements chez QVT Financial LP et directeur chez Myovant Sciences Ltd. Il a obtenu un diplôme d'études supérieures de la Yale Law School et un diplôme de premier cycle du Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROIVANT SCIENCES LTD.
6,63% | 02/04/2024 | 53 431 426 ( 6,63% ) | 563 M $ | 31/03/2024 |
Dernières actualités sur Vivek Ramaswamy
Postes actifs de Vivek Ramaswamy
| Sociétés | Poste | Début |
|---|---|---|
Strive Asset Management LLC
 Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The private company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | Founder | 01/01/2022 |
Anciens postes connus de Vivek Ramaswamy
| Sociétés | Poste | Fin |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2021 |
| ROIVANT SCIENCES LTD. | Chief Executive Officer | 01/01/2021 |
| MYOVANT SCIENCES LTD. | Chairman | 07/11/2018 |
| ARBUTUS BIOPHARMA CORPORATION | Chairman | 26/11/2018 |
| SIO GENE THERAPIES INC. | Chief Executive Officer | 07/04/2017 |
Formation de Vivek Ramaswamy
| Yale Law School | Graduate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| Entreprise privées | 10 |
|---|---|
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Finance |
Campus Venture Network, Inc.
 Campus Venture Network, Inc. Internet Software/ServicesTechnology Services Campus Venture Network, Inc. operates a website. The private company is based in Cary, NC. The company was founded by S. Travis May, Vivek Ramaswamy. | Technology Services |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The private company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | Finance |
